BDBM3160 2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzene)amido]tricyclo[5.2.1.0^{2,6}]decan-8-yl]oxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Balanol analog 26::CHEMBL263910

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CC(C3CCCC23)[C@H]1NC(=O)c1ccc(O)cc1

InChI Key InChIKey=SSMSJTVEHMWTFZ-UHFFFAOYSA-N

Data  19 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 19 hits for monomerid = 3160   

TargetProtein kinase C alpha type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C alpha isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 3.20E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C zeta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 3.70E+4nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C zeta isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C gamma isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 3.20E+4nMAssay Description:Inhibitory concentration against recombinant human cAMP-dependent Protein kinase AMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 970nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C epsilon isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 150nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C beta 1 isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C delta isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C eta isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 30nMAssay Description:Inhibitory concentration against recombinant human Protein kinase C beta 2 isozymeMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 100nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 3.20E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C zeta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 3.70E+4nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C eta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 970nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C delta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C gamma type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 50nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 30nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article

TargetProtein kinase C beta type(Human)
Eli Lilly

Curated by ChEMBL
LigandPNGBDBM3160(2-{[2,6-dihydroxy-4-({[(8R,9R)-9-[(4-hydroxybenzen...)
Affinity DataIC50: 150nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2005
Entry Details Article